How Real-World Data on Bispecifics Could Shape Follicular Lymphoma Practice

(MedPage Today) -- Real-world data presented at the American Society of Clinical Oncology (ASCO) annual meeting reinforced the effectiveness and safety of bispecific antibodies for relapsed or refractory follicular lymphoma, including in patients...